2024
DOI: 10.1536/ihj.23-614
|View full text |Cite
|
Sign up to set email alerts
|

Aspirin and Celecoxib Regulate Notch1/Hes1 Pathway to Prevent Pressure Overload-Induced Myocardial Hypertrophy

Minghui Wei,
Ziyu Lu,
Haifeng Zhang
et al.

Abstract: This study aimed to investigate the molecular mechanisms underlying the protective effects of cyclooxygenase (cox) inhibitors against myocardial hypertrophy.Rat H9c2 cardiomyocytes were induced by mechanical stretching. SD rats underwent transverse aortic constriction to induce pressure overload myocardial hypertrophy. Rats were subjected to echocardiography and tail arterial pressure in 12W. qPCR and western blot were used to detect the expression of Notch-related signaling. The inflammatory factors were test… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 44 publications
0
1
0
Order By: Relevance
“…A recent study utilizing H9C2 cells revealed that by maintaining mitochondria integrity, Ohwia caudata prevents doxorubicin-induced cardiotoxicity [ 156 ]. Additionally, H9C2 cells were used as a model for myocardial hypertrophy to discover the positive effects of the Cox inhibitors, aspirin, and celecoxib in protecting the heart from hypertrophy via their effects on the Notch1/Hes1 pathway [ 157 ].…”
Section: In Vitro Models For Cardiomyocyte Differentiationmentioning
confidence: 99%
“…A recent study utilizing H9C2 cells revealed that by maintaining mitochondria integrity, Ohwia caudata prevents doxorubicin-induced cardiotoxicity [ 156 ]. Additionally, H9C2 cells were used as a model for myocardial hypertrophy to discover the positive effects of the Cox inhibitors, aspirin, and celecoxib in protecting the heart from hypertrophy via their effects on the Notch1/Hes1 pathway [ 157 ].…”
Section: In Vitro Models For Cardiomyocyte Differentiationmentioning
confidence: 99%